Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
10/2008
10/23/2008WO2008053341A3 Bridged bicyclic indazoles as cannabinoid receptor ligands
10/23/2008WO2008021849A3 Novel compounds as antagonists or inverse agonists at opioid receptors
10/23/2008US20080262242 Process For the Production of Carboxanilides
10/23/2008US20080262066 azole compound of formula (I) or a pharmaceutically acceptable salt thereof is effective as a cannabinoid CB1 receptor inverse agonist or antagonist, which is useful for preventing or treating obesity and obesity-related metabolic disorders.
10/23/2008US20080261997 Use of aminoindazole derivatives for the inhibition of tau phosphorylation
10/23/2008US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis
10/23/2008US20080261987 Substituted piperazines
10/23/2008US20080261966 Bis-aryl sulfonamides
10/23/2008US20080261940 N-(1-Arylpyrazol-4L) Sulfonamides and their Use as Parasiticides
10/23/2008CA2687029A1 4-(4-trifluoromethyl-3-thiobenzoyl)pyrazoles, and use thereof as herbicides
10/23/2008CA2686942A1 4-(3-aminobenzoyl)-1-methylpyrazoles and the use thereof as herbicides
10/23/2008CA2683588A1 4-(3-aminobenzoyl)-1-ethylpyrazoles and the use thereof as herbicides
10/23/2008CA2683582A1 4-(3-aminobenzoyl)-1,3-dimethylpyrazoles and the use thereof as herbicides
10/23/2008CA2683461A1 Novel vanilloid receptor ligands and the use thereof for the production of pharmaceuticals
10/23/2008CA2682393A1 5-membered heterocyclic derivative and use thereof for medical purposes
10/22/2008EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives
10/22/2008EP1981851A1 Kinase inhibitors and methods of use thereof
10/22/2008EP1981837A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity
10/22/2008EP1658269B1 Fused compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/22/2008EP1603562A4 Sulfonyl-amidino containing and tetrahydropyrimidino containing compounds as factor xa inhibitors
10/22/2008CN101291914A Novel bicyclic sulfonamides for use as glucocorticoid receptor modulators in the treatment of inflammatory diseases
10/22/2008CN101291913A Azinyl-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/22/2008CN101291912A Pyrazole derivatives, compositions containing such compounds and methods of use
10/22/2008CN101291908A Immunosuppressant compounds and compositions
10/22/2008CN100427454C Method for producing difluoro-acetyl-acetic acid alkylesters
10/21/2008US7439366 Phenacylamine derivatives, process for their production and pesticides containing them
10/21/2008US7439342 Thrombopoietin mimetics
10/21/2008US7439262 Serotonergic 5-HT2 agonists; chemical stability; topical; length of therapeutic activity; 1-(2-Aminopropyl)-1H-indazole-6-carboxylic acid ethyl ester
10/16/2008WO2008123469A1 Six-membered amide compound and use thereof
10/16/2008WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative
10/16/2008WO2008123207A1 Ornithine derivative
10/16/2008WO2008122787A1 Piperazine compounds for the inhibition of haematopoietic prostaglandin d synthase
10/16/2008WO2008122618A1 Selective inhibitors of cb2 receptor expression and/or activity for the treatment of obesity and obesity-related disorders
10/16/2008WO2008064615A3 Crystalline and amorphous forms of rimonabant and processes for obtaining them
10/16/2008WO2008057862A3 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ϰB ACTIVITY AND USE THEREOF
10/16/2008WO2008024302A3 Compounds for treating proliferative disorders
10/16/2008US20080255221 Novel hydroxamates as therapeutic agents
10/16/2008US20080255214 Novel hydroxamates as therapeutic agents
10/16/2008US20080255202 Phenylthioacetic Acid Derivatives and Use Thereof
10/16/2008US20080255182 Certain chemical entities, compositions, and methods
10/16/2008US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread
10/16/2008US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes
10/16/2008US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia
10/16/2008US20080254992 Controlling broadleaf plants, weeds, grasses
10/16/2008US20080254991 4-(3-Aminobenzoyl)-1-ethylpyrazoles and their use as herbicides
10/16/2008US20080254990 Applying to unwanted plants or weeds; controlling broadleaf plants
10/16/2008CA2681861A1 Ornithine derivative
10/15/2008EP1980556A1 4-(4-trifluor methyl-3-thiobenzoyl) pyrazoles and their application as herbicides
10/15/2008EP1980555A1 4-(3-aminobenzoyl)-1.3-dimethyl pyrazoles and their application as herbicides
10/15/2008EP1980554A1 4-(3-aminobenzoyl)-1-ethyl pyrazoles and their application as herbicides
10/15/2008EP1980553A1 4-(3-aminobenzoyl)-1-methyl pyrazoles and their application as herbicides
10/15/2008EP1979323A1 Process for the stereoselective preparation of alcohols from alpha, beta-insaturated compounds
10/15/2008EP1979311A2 Phenoxy acetic acids as ppar delta activators
10/15/2008EP1747201B1 2h or 3h-benzo[e]indazol-1-yle carbamate derivatives, the preparation and therapeutic use thereof
10/15/2008EP1692124B1 Biaryl sulfonamides as mmp inhibitors
10/15/2008EP1660455B1 Fused azabicyclic compounds that inhibit vanilloid receptor subtype 1 (vr1) receptor
10/15/2008EP1476423B1 Arylsulfonamidobenzylic compounds
10/15/2008EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities
10/15/2008CN101287721A 酰肼化合物和其杀虫用途 Hydrazide compounds and their insecticidal use
10/15/2008CN101287710A Preparation of 4,5-diamino-1-(substituted)-pyrazole and acid addition salts thereof
10/15/2008CN101284815A Pyrazoleoxy acetic acid compounds, preparation method and use
10/15/2008CN101284814A Method for producing acrylonitrile compound
10/15/2008CN100425607C Method for controlling particular insects by applying anthranilamide compounds
10/14/2008US7435829 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
10/14/2008US7435815 Sulfonylamino-acetic acid derivatives
10/14/2008US7435753 1-aryl-4-cyclopropylpyrazoles with at least one fluorine attached to the cyclopropyl ring; Coupling of an aryldiazonium salt with a 2,3-dicyano-3-cyclopropyl propanoate; parasiticides; fleas; Extended duration of action for at least 28 days
10/14/2008US7435728 Pyrazole derivatives
10/14/2008CA2346142C Process for preparing 1,5-diaryl-3-substituted pyrazoles
10/14/2008CA2309328C Cyclic amine derivatives and their use as drugs
10/14/2008CA2222138C Method of preparing 3-haloalkyl-1h-pyrazoles
10/09/2008WO2008121861A2 Pyrazole and pyrrole compounds useful in treating iron disorders
10/09/2008WO2008120708A1 Engraftment enhancer or proliferation enhancer in tissue plantation
10/09/2008WO2008057873A3 Inhibitors of hepatitis c virus
10/09/2008WO2008057871A3 Inhibitors of hepatitis c virus
10/09/2008WO2008044153A3 Improved method for synthesizing rimonabant
10/09/2008US20080249290 Colorant compounds
10/09/2008US20080249154 Preventive and/or Therapeutic Agent For Disease In Which Mitochondrial Benzodiazephine Receptor Participates
10/09/2008US20080249150 Heterocyclic sulfonamide inhibitors of beta amyloid production containing an azole
10/09/2008US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease
10/09/2008US20080249095 tyrosine kinase inhibitors, in particular Met kinase; antitumor agents;1-(Benzo-1,2,5-thiadiazol-5-ylmethylcarbonyl)-3-(2,4-dimethoxyphenyl)-4,5-dihydro-1H-pyrazole; leukemia, carcinomas
10/09/2008US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide
10/08/2008EP1978019A1 3-phenyl-pyrazole derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
10/08/2008EP1977749A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
10/08/2008EP1976511A2 Fluorinated arylamide derivatives
10/08/2008EP1633348B1 4- BROMO - 5 - (2- CHLORO - BENZOYLAMINO) - 1H - PYRAZOLE - 3 - CARBOXYLIC ACID AMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ B sb 1 /sb RECEPTOR ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY DISEASES
10/08/2008EP1606283B1 P38 inhibitors and methods of use thereof
10/08/2008EP1597234B1 Novel compounds
10/08/2008EP1389100B1 Novel methods for the treatment and prevention of pain using stress-activated protein kinase inhibitors
10/08/2008EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS
10/08/2008CN101282972A Piperidine and piperazine derivatives as P2X3 antagonists
10/08/2008CN101282939A Diacyl indazole derivatives as lipase and phospholipase inhibitors
10/08/2008CN101282938A Substituted-3-sulfonylindazole derivatives as 5-hydroxytryptamine-6 ligands
10/08/2008CN101282937A Therapeutic agents
10/08/2008CN101282936A Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
10/08/2008CN101279946A Synthetic method of pyrazoles
10/08/2008CN100423721C Thrombopoietin mimetics
10/07/2008US7432379 3-Amido-5-substituted pyrazole derivatives and related compounds useful as bradykinin B1 receptor antagonists to relieve adverse symptoms in mammals mediated, at least in part, by bradykinin B1 receptor including pain, inflammation, septic shock, scarring process
10/07/2008US7432287 e.g. 3-(6-ethanesulfonylpyridin-3-yloxy)-5-(2-hydroxy-1-methyl-ethoxy)-N-(1-methyl-1H-pyrazol-3-yl)benzamide; glucokinase activator; antidiabetic agent; obesity, insulin resistance
10/07/2008US7432285 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/07/2008US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 256